Search Results - "Natraj R Ammakkanavar"

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers by Radovich, Milan, Kiel, Patrick J, Nance, Stacy M, Niland, Erin E, Parsley, Megan E, Ferguson, Meagan E, Jiang, Guanglong, Ammakkanavar, Natraj R, Einhorn, Lawrence H, Cheng, Liang, Nassiri, Mehdi, Davidson, Darrell D, Rushing, Daniel A, Loehrer, Patrick J, Pili, Roberto, Hanna, Nasser, Callaghan, J Thomas, Skaar, Todd C, Helft, Paul R, Shahda, Safi, O'Neil, Bert H, Schneider, Bryan P

“…Patients with metastatic solid tumors who had progressed on at least one line of standard of care therapy were referred to the Indiana University Health…”
Get full text

Adjuvant therapy for endometrial cancer by Deleon, Maria C, Ammakkanavar, Natraj R, Matei, Daniela

“…Endometrial cancer is a common gynecologic malignancy typically diagnosed at early stage and cured with surgery alone. Adjuvant therapy is tailored according…”
Get full text

Adjuvant therapy for endometrial cancer by Maria C Deleon, Natraj R Ammakkanavar, Daniela Matei

“…Endometrial cancer is a common gynecologic malignancy typically diagnosed at early stage and cured with surgery alone. Adjuvant therapy is tailored according…”
Get full text

Impact of dialysis requirement on outcomes in tumor lysis syndrome by Garimella, Pranav S., Balakrishnan, Poojitha, Ammakkanavar, Natraj R., Patel, Shanti, Patel, Achint, Konstantinidis, Ioannis, Annapureddy, Narender, Nadkarni, Girish N.

“…Tumor lysis syndrome (TLS) is a life threatening emergency due to destruction and massive release of intracellular metabolites from cancer cells often…”
Get full text

Abstract CT158: A dose escalation and cohort expansion study of the CDK9 inhibitor KB-0742 in relapsed, refractory and transcriptionally addicted solid tumors by Calero, Miguel Villalona, Agulnik, Mark, Mita, Monica, Mita, Alain, Federman, Noah, Rasco, Drew, Spigel, David, Luo, Jia, Hanna, Glenn, Cote, Gregory, Salkeni, Mohamad A., Chugh, Rashmi, Ammakkanavar, Natraj R., Shah, Satish A., Rao, Amol, Sankhala, Kamalesh Kumar, Cutler, Richard E., Hood, Tressa, Carvajal, Luis, MacKenzie, Crystal, Lin, Charles, DiMartino, Jorge, Olek, Elizabeth A., Van Tine, Brian

“…Background MYC transcriptional deregulation is a hallmark of cancer and is associated with poor clinical outcomes. MYC deregulated solid tumors including…”
Get full text

Older Age and Co-Morbidities Do Not Predict Incidence of Dose Limiting Toxicities in Lymphoma Phase I Trials At MSKCC by Ammakkanavar, Natraj R, Leon, Chady Abboud, Hamlin, Paul

“…Abstract 3145 Historically, older adults are underrepresented in clinical trials despite bearing a disproportionate burden of cancer. Nearly 60% of all new…”
Get full text